Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents

por Salem, Ahmed F., Gambini, Luca, Udompholkul, Parima, Baggio, Carlo, Pellecchia, Maurizio
Publicado 2020

Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model

por Salem, Ahmed F., Gambini, Luca, Billet, Sandrine, Sun, Yu, Oshiro, Hiromichi, Zhao, Ming, Hoffman, Robert M., Bhowmick, Neil A., Pellecchia, Maurizio
Publicado 2020

hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents

por Barile, Elisa, Marconi, Guya D., De, Surya K., Baggio, Carlo, Gambini, Luca, Salem, Ahmed F., Kashyap, Manoj K., Castro, Januario E., Kipps, Thomas J., Pellecchia, Maurizio
Publicado 2016

Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide–Drug Conjugate

por Salem, Ahmed F., Wang, Si, Billet, Sandrine, Chen, Jie-Fu, Udompholkul, Parima, Gambini, Luca, Baggio, Carlo, Tseng, Hsian-Rong, Posadas, Edwin M., Bhowmick, Neil A., Pellecchia, Maurizio
Publicado 2018

Two-compartment tumor metabolism: Autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells

por Salem, Ahmed F., Whitaker-Menezes, Diana, Lin, Zhao, Martinez-Outschoorn, Ubaldo E., Tanowitz, Herbert B., Al-Zoubi, Mazhar Salim, Howell, Anthony, Pestell, Richard G., Sotgia, Federica, Lisanti, Michael P.
Publicado 2012